Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
10.1038/nm.2091
Saved in:
Main Authors: | Janes, M.R., Limon, J.J., So, L., Chen, J., Lim, R.J., Chavez, M.A., Vu, C., Lilly, M.B., Mallya, S., Ong, S.T., Konopleva, M., Martin, M.B., Ren, P., Liu, Y., Rommel, C., Fruman, D.A. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/124648 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Targeting of the MNK-eIF4E axis in blast crisis Chronic myeloid leukemia inhibits leukemia stem cell function
by: Lim, S., et al.
Published: (2014) -
Mapping the interaction of Snf1 with TORC1 in Saccharomyces cerevisiae
by: Zhang, J, et al.
Published: (2020) -
Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase
by: Zemskova, M., et al.
Published: (2011) -
PRL-3 activates mTORC1 in Cancer Progression
by: Ye, Z, et al.
Published: (2020) -
Potential roles for the PIM1 kinase in human cancer - A molecular and therapeutic appraisal
by: Shah, N., et al.
Published: (2012)